FDA Ushers in New Program for Drug Products Manufactured Using Innovative Manufacturing Technologies | King & Spalding

Under Section 3213 of Food and Drug Omnibus Reform Act, the U.S. Food & Drug Administration (“FDA” or the “Agency”) is required to establish the Advanced Manufacturing Technologies...

Related Keywords

Ndas Blas ,King Spalding ,Technology Team ,Congress Modernizes ,Manufacturing Technologies Designation Program ,Us Food Drug Administration ,Manufacturing Technologies Designation Program Dec ,Drug Omnibus Reform Act ,Drug Administration ,Emerging Technology Team ,Drug Evaluation ,Advanced Technology Team ,Biologics Evaluation ,Client Alert ,Not Quite ,Drug Omnibus Reform Act Rescues Some ,Drug Admin ,Drug Shortages ,Calendar Year ,Biologics License Applications ,Master Files ,Draft Guidance ,Accepted Scientific ,Support Drug ,Biologic Applications ,